ConductScience.org, home

Gene · 3433

IFIT2: interferon induced protein with tetratricopeptide repeats 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. IFIT2: interferon induced protein with tetratricopeptide repeats 2. Genes, record 3433. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3433

On this page

Gene

Symbol
IFIT2
HGNC
Name
interferon induced protein with tetratricopeptide repeats 2
HGNC
NCBI Gene ID
3433
NCBI Gene
HGNC ID
HGNC:5409
HGNC
Ensembl
ENSG00000119922
NCBI Gene
Aliases
G10P2, GARG-39, IFI-54, IFI-54K, IFI54, IFIT-2, ISG-54, ISG-54 K, ISG-54K, ISG54, P54, cig42
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P09913Interferon-induced protein with tetratricopeptide repeats 24721Ensembl, GeneID, HGNC

Source UniProt

Patents21

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1450109P09913Espacenet
EP 4641201 A22025-10-299269P09913Espacenet
JP 2025517969 A2025-06-129269P09913Espacenet
US 11446398 B22022-09-2041253P09913Espacenet
JP 2022524081 A2022-04-27144224P09913Espacenet
US 11078247 B22021-08-035313P09913Espacenet
WO 2021070107 A12021-04-152P09913Espacenet
US 10846371 B22020-11-246P09913Espacenet
JP 2019054813 A2019-04-11230544P09913Espacenet
KR 1020190016302 A2019-02-1856P09913Espacenet

1 to 10 of 21

See all 21 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants2,804

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleIFIT2 papersNewest fiscal year
P30CA008748Cancer Center Support Grant112025
P30CA016672Cancer Center Support Grant82025
P01AI120943Molecular Mechanisms of Filoviral-host Interactions72025
T32AI007647Training Program in Mechanisms of Virus-Host Interactions72025
P30CA016058Cancer Center Support Grant62025
P51OD011092Support for National Primate Research Center62025
P51OD011132Emory National Primate Research Center62025
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged62025
U19AI135972SARS-CoV adaptations through a Systems Biology Lens (SYBIL)62025
UL1TR001863Yale Clinical and Translational Science Award62025

1 to 10 of 2,804Source NIH's project files

See all 2,804 nih grants

Papers3,694

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
The Silent Vehicle: Validating the Biological Signals and Noises of Baculovirus Vectors in Macrophage-Targeted Vaccines.Vaccines (Basel)202642797636PubTator, text miningPubMed
Development and Evaluation of Three Indirect ELISA Methods Based on Novel Recombinant ASFV Antigens for Serological Detection of African Swine Fever.Pathogens202642796751PubTator, text miningPubMed
Evaluation of An I226R and A137R deletion mutant from a genotype I/II recombinant African swine fever virus strain as a live attenuated vaccine in pigs.Vet Res202642665846PubTator, text miningPubMed
Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.Ann Rheum Dis202642618420PubTator, text miningPubMed
Systems-level insights into age-dependent innate immune responses in influenza B infection.Microbiol Spectr202642615604PubTator, text miningPubMed
Novel Linear B Cell Epitopes of ASFV p54: Screening and Fine-Scale Mapping.Microorganisms202642513912PubTator, text miningPubMed
Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control.Tissue Eng Regen Med202642467368PubTator, text miningPubMed
An integrative epigenomic and single-cell framework identifies a prognostic DNA methylation risk score and ZNF638 silencing in urothelial carcinoma.J Transl Med202642443907PubTator, text miningPubMed
1D-2D hybrid based electrochemical sensor for nano-architected sensing of ASFV p32 - an early phosphoprotein.Biosens Bioelectron202642425003PubTator, text miningPubMed
Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.Exp Dermatol202642410891PubTator, text miningPubMed

1 to 10 of 3,694

See all 3,694 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/3433

GET https://conductscience.org/api/genes/v1/3433/patents?page=2